Labeling & Claims

What You Need Before Claiming Non-Comedogenic

Non-comedogenic is a testing claim, not a marketing adjective, and printing it without evidence behind it is a bigger risk than most makers assume.

The Compliance Desk3 min read

"Non-comedogenic" sounds like a formulation fact, something you can just look at your oil phase and decide. It is not. It is a testing claim, meaning it is only as good as the evidence you have sitting in a file somewhere, ready to be produced if anyone ever asks how you know.

What the claim is actually asserting

A non-comedogenic claim tells the consumer, specifically, that your product does not clog pores or contribute to comedone formation, the plugged follicles that show up as blackheads and whiteheads. This is a narrower and more testable claim than something vague like "gentle" or "won't break you out," which is exactly why it carries more substantiation weight. You are not just saying the product feels light. You are saying it has been evaluated for a specific biological effect and came back clean.

Where the pore-clogging concern actually comes from

Comedogenicity concerns trace back to specific raw materials more than finished formulas. Certain oils and waxes have reputations, earned or partly outdated, for higher comedogenic potential: some heavier plant butters, certain mineral oil grades from decades ago, isopropyl myristate in high concentrations, and a handful of other emollients that appear repeatedly in comedogenicity rating lists compiled over the years from various studies.

The problem is that comedogenicity ratings for individual ingredients do not automatically transfer to a finished, multi-ingredient product. An oil rated moderately comedogenic in isolation might behave differently diluted at 2% inside a finished emulsion with other ingredients around it. This is exactly why a non-comedogenic claim on the finished product is a different, and generally more defensible, thing than just picking ingredients off a "low comedogenic" list and assuming the claim follows automatically.

What substantiation typically looks like

There is not one single mandated test protocol universally required, which is part of what makes this claim tricky to get consistently right across the industry. But the substantiation a maker should have on file generally includes one or more of:

  • Rabbit ear assay or human patch testing historically used to establish comedogenicity ratings for raw materials, though this methodology has real limitations and is used less today
  • Human use testing on acne-prone or comedogenic-prone panelists, using the actual finished formula rather than individual raw materials, over a defined period, typically several weeks
  • Dermatologist-supervised clinical evaluation of the finished product, with photographic or physical assessment of comedone formation before and after use

The key point: your substantiation should be on the finished formula you are actually selling, done by a qualified party, with a written report you can produce. A claim based purely on "we used ingredients that are generally considered non-comedogenic" is thinner ground than a claim backed by testing on the actual product.

Why this matters more than it might seem

Skincare claims aimed at acne-prone consumers get more scrutiny, informally and formally, than most other cosmetic claims, because the audience buying the product is specifically trying to avoid a known problem. If your product does in fact contribute to breakouts and you have claimed non-comedogenic without substantiation, that is a straightforward false-claim exposure, separate entirely from your ingredient safety and notification obligations.

Keeping this separate from your notification filing

Non-comedogenic is a labeling and advertising claim. It sits outside your Cosmetic Notification Form, which is about ingredient disclosure, not marketing language. Health Canada's notification system does not evaluate or approve your claims, it is a notification of ingredients, not a claims-clearance process. That means the substantiation burden for "non-comedogenic" rests entirely on you, documented and ready, independent of whatever CN number you receive.

If you are building out a claims file for a new product line, keep the non-comedogenic evidence with your other claim substantiation records, separate from your CNF paperwork, since the two live in different regulatory buckets and get reviewed by different people if either is ever questioned. Cosmetic Comply handles the ingredient side, INCI mapping, CAS numbers, and Hotlist screening, but a claim like this one is a testing and evidence question you'll want a qualified claims reviewer or dermatology consultant to weigh in on directly.

READY TO FILE?

Send your ingredients and we take it from here

A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.

Start a filing

Keep reading